We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine

News   Mar 21, 2013

 
RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine
 
 
Advertisement
 

RELATED ARTICLES

A Novel Way To Deliver More Drugs Through the Skin

News

By applying “temporal pressure” to the skin of mice, researchers have shown that the pressure technique can be used to create a novel drug delivery approach.

READ MORE

Team Develops Synthetic Blood-Thinner With No Bleeding Side Effects

News

Scientists have developed a highly selective and highly stable synthetic blood-thinning molecule that, unlike others, doesn’t cause bleeding adverse effects.

READ MORE

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE